Friday , September 20 2019
Home / philippines / Mundipharma Announces the License Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medi – PharmiWeb.com

Mundipharma Announces the License Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medi – PharmiWeb.com




Mundipharma Announces the License Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medi PharmiWeb.com

The license extension submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to treat type 2 diabetes mellitus (T2DM) patients …


Source link